ROYCE & ASSOCIATES LP

Position in ABSI — Absci Corp

CIK 906304 New York, NY

Position in ABSI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,206,059

-$360,322 QoQ

Shares Held

735,353

0.0% QoQ

Ownership

0.472%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. ABSI ranks #21 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	2,089,906	$51,746,072
2	TECH	BIO-TECHNE Corp	759,712	$39,702,549
3	INVA	Innoviva, Inc.	1,061,448	$24,731,738
4	BBIO	BridgeBio Pharma, Inc.	232,923	$17,296,861
5	AXSM	Axsome Therapeutics, Inc.	94,017	$15,890,753
6	ORIC	Oric Pharmaceuticals, Inc.	1,207,223	$15,295,515
7	CRMD	CorMedix Inc.	1,887,532	$12,816,342
8	CNTA	Centessa Pharmaceuticals plc	278,064	$11,044,702

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,206,059	735,353	0.0%	Shares	Sole	2026-05-12
2025-12-31	$2,566,381	735,353	-41.7%	Shares	Sole	2026-02-09
2025-09-30	$3,834,756	1,261,433	-16.9%	Shares	Sole	2025-11-12
2025-06-30	$3,903,313	1,518,799	+24.6%	Shares	Sole	2025-08-11
2025-03-31	$3,059,185	1,218,799	+38.2%	Shares	Sole	2025-05-06
2024-12-31	$2,311,091	882,096	+472.1%	Shares	Sole	2025-02-10
2024-09-30	$589,009	154,191	-19.9%	Shares	Sole	2024-11-06
2024-06-30	$592,878	192,493	+45.8%	Shares	Sole	2024-08-13
2024-03-31	$749,822	132,011	-66.0%	Shares	Sole	2024-05-13
2023-12-31	$1,628,646	387,773	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.